Literature DB >> 31199471

Progressive agrammatic aphasia without apraxia of speech as a distinct syndrome.

Katerina A Tetzloff1, Joseph R Duffy2, Heather M Clark2, Rene L Utianski2, Edythe A Strand2, Mary M Machulda3, Hugo Botha2, Peter R Martin4, Christopher G Schwarz1, Matthew L Senjem1, Robert I Reid1, Jeffrey L Gunter1, Anthony J Spychalla1, David S Knopman2, Ronald C Petersen2, Clifford R Jack1, Val J Lowe1, Keith A Josephs2, Jennifer L Whitwell1.   

Abstract

Agrammatic aphasia affects grammatical language production and can result from a neurodegenerative disease. Although it typically presents with concomitant apraxia of speech, this is not always the case. Little is known about the clinical course and imaging features of patients that present with agrammatism in the absence of apraxia of speech, which we will refer to as progressive agrammatic aphasia. We aimed to make a detailed description of the longitudinal clinical, linguistic, and neuroimaging features of a cohort of 11 patients with progressive agrammatic aphasia to provide a complete picture of this syndrome. All patients underwent detailed speech and language, neurological and neuropsychological assessments, 3 T structural and diffusion tensor imaging MRI, 18F-fluorodeoxyglucose and Pittsburgh compound B PET. The 11 patients were matched by age and gender to 22 patients who had mixed apraxia of speech and agrammatism. The progressive agrammatic aphasia patients performed abnormally on tests of language, general cognition, executive function, and functional ability at baseline and declined in these measures over time. Only two patients eventually developed apraxia of speech, while parkinsonism was absent-to-mild throughout all visits for all patients. When compared to the patients with mixed apraxia of speech and agrammatism, the patients with progressive agrammatic aphasia performed better on tests of motor speech and parkinsonism but more poorly, and declined faster over time, on tests of general aphasia severity, agrammatism, and naming. The patients with progressive agrammatic aphasia also showed different neuroimaging abnormalities, with greater atrophy, hypometabolism and white matter tract degeneration in the prefrontal and anterior temporal lobes compared to patients with mixed apraxia of speech and agrammatism. These differences were more pronounced as the disease progressed. These results demonstrate that progressive agrammatic aphasia has a different clinical disease course and different underlying neuroanatomical abnormalities than patients with the more common syndrome of mixed agrammatism and apraxia of speech. This supports the distinction of progressive agrammatic aphasia and has implications for the classification of patients with agrammatic aphasia.
© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  MRI; agrammatic; aphasia; longitudinal; positron emission tomography

Mesh:

Year:  2019        PMID: 31199471      PMCID: PMC6658844          DOI: 10.1093/brain/awz157

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  62 in total

1.  The token test: A sensitive test to detect receptive disturbances in aphasics.

Authors:  E DE RENZI; L A VIGNOLO
Journal:  Brain       Date:  1962-12       Impact factor: 13.501

2.  Unified segmentation.

Authors:  John Ashburner; Karl J Friston
Journal:  Neuroimage       Date:  2005-04-01       Impact factor: 6.556

3.  Patterns of brain atrophy in frontotemporal dementia and semantic dementia.

Authors:  H J Rosen; M L Gorno-Tempini; W P Goldman; R J Perry; N Schuff; M Weiner; R Feiwell; J H Kramer; B L Miller
Journal:  Neurology       Date:  2002-01-22       Impact factor: 9.910

4.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

5.  Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.

Authors:  K A Josephs; B F Boeve; J R Duffy; G E Smith; D S Knopman; J E Parisi; R C Petersen; D W Dickson
Journal:  Neurocase       Date:  2005-08       Impact factor: 0.881

6.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

7.  Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory.

Authors:  D I Kaufer; J L Cummings; P Ketchel; V Smith; A MacMillan; T Shelley; O L Lopez; S T DeKosky
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

8.  Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech.

Authors:  Keith A Josephs; Joseph R Duffy; Edyth A Strand; Jennifer L Whitwell; Kenneth F Layton; Joseph E Parisi; Mary F Hauser; Robert J Witte; Bradley F Boeve; David S Knopman; Dennis W Dickson; Clifford R Jack; Ronald C Petersen
Journal:  Brain       Date:  2006-04-13       Impact factor: 13.501

9.  An empirically derived short form of the Boston naming test.

Authors:  A E Lansing; R J Ivnik; C M Cullum; C Randolph
Journal:  Arch Clin Neuropsychol       Date:  1999-08       Impact factor: 2.813

10.  Cognition and anatomy in three variants of primary progressive aphasia.

Authors:  Maria Luisa Gorno-Tempini; Nina F Dronkers; Katherine P Rankin; Jennifer M Ogar; La Phengrasamy; Howard J Rosen; Julene K Johnson; Michael W Weiner; Bruce L Miller
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

View more
  12 in total

1.  Assessing Change in Communication Limitations in Primary Progressive Apraxia of Speech and Aphasia: A 1-Year Follow-Up Study.

Authors:  Rene L Utianski; Peter R Martin; Joseph R Duffy; Hugo Botha; Heather M Clark; Keith A Josephs
Journal:  Am J Speech Lang Pathol       Date:  2021-09-07       Impact factor: 4.018

2.  Survival Analysis in Primary Progressive Apraxia of Speech and Agrammatic Aphasia.

Authors:  Jennifer L Whitwell; Peter Martin; Joseph R Duffy; Heather M Clark; Rene L Utianski; Hugo Botha; Mary M Machulda; Edythe A Strand; Keith A Josephs
Journal:  Neurol Clin Pract       Date:  2021-06

3.  Cross-Sectional and Longitudinal Assessment of Behavior in Primary Progressive Apraxia of Speech and Agrammatic Aphasia.

Authors:  Fatma Ozlem Hokelekli; Joseph R Duffy; Heather M Clark; Rene L Utianski; Hugo Botha; Julie A Stierwalt; Edythe A Strand; Mary M Machulda; Jennifer L Whitwell; Keith A Josephs
Journal:  Dement Geriatr Cogn Disord       Date:  2022-05-06       Impact factor: 3.346

4.  The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.

Authors:  Zeynep Idil Seckin; Joseph R Duffy; Edythe A Strand; Heather M Clark; Rene L Utianski; Mary M Machulda; Hugo Botha; Farwa Ali; Nha Trang Thu Pham; Val J Lowe; Jennifer L Whitwell; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2020-10-07       Impact factor: 4.891

5.  An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant.

Authors:  Jennifer L Whitwell; Chase A Stevens; Joseph R Duffy; Heather M Clark; Mary M Machulda; Edythe A Strand; Peter R Martin; Rene L Utianski; Hugo Botha; Anthony J Spychalla; Matthew L Senjem; Christopher G Schwarz; Clifford R Jack; Farwa Ali; Anhar Hassan; Keith A Josephs
Journal:  Mov Disord Clin Pract       Date:  2019-05-29

6.  Progressive apraxia of speech: delays to diagnosis and rates of alternative diagnoses.

Authors:  Johnny Dang; Jonathan Graff-Radford; Joseph R Duffy; Rene L Utianski; Heather M Clark; Julie A Stierwalt; Jennifer L Whitwell; Keith A Josephs; Hugo Botha
Journal:  J Neurol       Date:  2021-05-04       Impact factor: 4.849

7.  A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech.

Authors:  Keith A Josephs; Joseph R Duffy; Heather M Clark; Rene L Utianski; Edythe A Strand; Mary M Machulda; Hugo Botha; Peter R Martin; Nha Trang Thu Pham; Julie Stierwalt; Farwa Ali; Marina Buciuc; Matthew Baker; Cristhoper H Fernandez De Castro; Anthony J Spychalla; Christopher G Schwarz; Robert I Reid; Matthew L Senjem; Clifford R Jack; Val J Lowe; Eileen H Bigio; Ross R Reichard; Eric J Polley; Nilufer Ertekin-Taner; Rosa Rademakers; Michael A DeTure; Owen A Ross; Dennis W Dickson; Jennifer L Whitwell
Journal:  Nat Commun       Date:  2021-06-08       Impact factor: 17.694

8.  Graded, multidimensional intra- and intergroup variations in primary progressive aphasia and post-stroke aphasia.

Authors:  Ruth U Ingram; Ajay D Halai; Gorana Pobric; Seyed Sajjadi; Karalyn Patterson; Matthew A Lambon Ralph
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

9.  Longitudinal anatomic, functional, and molecular characterization of Pick disease phenotypes.

Authors:  Jennifer L Whitwell; Nirubol Tosakulwong; Christopher C Schwarz; Matthew L Senjem; Anthony J Spychalla; Joseph R Duffy; Jon Graff-Radford; Mary M Machulda; Bradley F Boeve; David S Knopman; Ronald C Petersen; Val J Lowe; Clifford R Jack; Dennis W Dickson; Joseph E Parisi; Keith A Josephs
Journal:  Neurology       Date:  2020-09-28       Impact factor: 9.910

10.  Neuropsychological Profiles of Patients with Progressive Apraxia of Speech and Aphasia.

Authors:  Angelina J Polsinelli; Mary M Machulda; Peter R Martin; Joseph R Duffy; Heather M Clark; Alissa M Butts; Hugo Botha; Val J Lowe; Jennifer L Whitwell; Keith A Josephs; Rene L Utianski
Journal:  J Int Neuropsychol Soc       Date:  2021-07-22       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.